Article Details

AstraZeneca's severe asthma treatment approved in EU for self-administration - PMLiVE

Retrieved on: 2023-01-13 12:58:08

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's severe asthma treatment approved in EU for self-administration - PMLiVE. View article details on hiswai:

Excerpt

AstraZeneca's Tezspire (tezepelumab) has been approved for self-administration in patients with severe asthma aged 12 years and older after it ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up